C Steven Gilman
Affiliations
- at Akebia Therapeutics Inc. (AKBA), 2025-06-11
- at Vericel Corp (VCEL), 2024-10-18
- at Scynexis Inc (SCYX), 2024-06-21
- Director at Contrafect Corp (CFRX), 2022-05-18
- Director at Momenta Pharmaceuticals Inc (MNTA), 2020-10-01
- Director at Keryx Biopharmaceuticals Inc (KERX), 2018-12-13
- Evp & Chief Scientific Officer at Cubist Pharmaceuticals Inc (CBST), 2015-01-21
Insider Trading: Purchases See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| SCYX | $6.25 | 4,000 | $25,000.00 | 4,000 | 2020-12-21 | Filing |
| AKBA | $3.43 | 5,800 | $19,894.00 | 29,731 | 2019-11-20 | Filing |
| CFRX | $1.24 | 800 | $992.00 | 20,800 | 2017-07-25 | Filing |
| CFRX | $2.48 | 20,000 | $49,600.00 | 20,000 | 2016-07-27 | Filing |
Insider Trading: Sales See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| VCEL | $41.36 | 5,833 | $241,252.88 | 11,000 | 2024-10-16 | Filing |
| VCEL | $40.35 | 5,833 | $235,361.55 | 11,000 | 2024-10-02 | Filing |
| VCEL | $45.54 | 5,834 | $265,680.36 | 11,000 | 2024-09-18 | Filing |
| VCEL | $48.58 | 5,000 | $242,900.00 | 11,000 | 2024-09-04 | Filing |
| AKBA | $0.36 | 4,567 | $1,653.25 | 43,430 | 2022-06-03 | Filing |